期刊文献+

急性脑梗死溶栓治疗研究进展 被引量:26

Research progress on thrombolytic therapy in the treatment of acute ischemic stroke
下载PDF
导出
摘要 脑梗死严重威胁着人类生命健康和生活质量。近年来研究发现,溶栓治疗是目前国内外唯一公认的挽救缺血脑组织积极有效的治疗方式。本文综述了溶栓的常用药物、治疗时间窗、常用方法及并发症,提示:掌握溶栓的治疗时机、用药剂量、治疗方法等情况,对于改善患者预后、提高生活质量及最大限度地减少并发症具有重要意义。 Ischemic stroke exerts profound effectd on human health and the quality of life.Recent studies revealed that thrombolytic therapy is regarded to be the only effective therapy to retrieve ischemic brain tissue.This article reviews thrombolytic therapy in the treatment of acute ischemic stroke,including the general drugs,time of therapy,general method and complications.The mastering of thrombolytic therapy is of great significance to improve the patients’ prognosis and the quality of life.
出处 《海南医学》 CAS 2012年第13期113-116,共4页 Hainan Medical Journal
关键词 脑梗死 溶栓 时间窗 并发症 Ischemic stroke; Thrombolytic therapy; Time of therapy; Complication
  • 相关文献

参考文献23

二级参考文献48

  • 1贺茂林,陈清棠.急性脑梗死溶栓治疗的血管再通率[J].中华老年心脑血管病杂志,1999,1(1):57-60. 被引量:36
  • 2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33009
  • 3脑卒中患者临床神经功能缺损程度评分标准(1995)[J].中华神经科杂志,1996,29(6):381-383. 被引量:15713
  • 4[1]史玉泉.神经病学新理论与新技术[M].上海科学技术出版社,1995.250-253.
  • 5[3]Zoppo GJ,Poeck K,Pessin MS,et al.Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke[J].Ann Neurol,1992,32:78-86.
  • 6[4]Kanter D,Kothari R,Pancioli A,et al.The greater cinnati t-PA experience after the NINDS trial:does a longer time to treatment within the current three-hour window reduce efficacy[J]? Stroke,1999,30:244.
  • 7The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.Tissue plasminogen activator for acute ischemic stroke.N Engl J Med,1995,333:1581-1588.
  • 8The ECASS study Group.Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke:the European cooperative acute stroke study (ECASS).JAMA,1995,274:1017-1025.
  • 9Antithrombotic and thrombolytic therapy for ischemic stroke:the seventh ACCP conference on antithrombotic and thrombolytic therapy.Chest,2004,126:483-512.
  • 10Hacke W,Bluhmki E,Steiner T,et al.Dichotomized efficacy end global end-point analysis applied to the ECASS Ⅰ.Stroke,1998,29:2073-2075.

共引文献506

同被引文献315

引证文献26

二级引证文献218

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部